Thoracic Vascular Stent Grafts Market Size & Share, by Type (Plastic, Metal); Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular); Application (Cardiac Aneurysm, Cardiovascular Diseases, Kidney Failure); End-user (Hospitals, Ambulatory Surgical Centers, Medical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4304
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Thoracic Vascular Stent Grafts Market size is poised to cross USD 284 Million by the end of 2035, growing at a CAGR of 6% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of thoracic vascular stent grafts was over USD 195 Million. The growth of the market can be attributed to the increasing prevalence of cardiovascular diseases throughout the world. According to the data provided by the World Health Organization (WHO), every year, approximately 17.9 million individuals die from CVDs throughout the world, accounting for 32% of all deaths. Further, dramatically changing eating habits, and evolving lifestyles are some further factors that are anticipated to boost the growth of the global thoracic vascular stent grafts market over the projected time frame.

In addition to these, factors that are believed to fuel the market growth of thoracic vascular stent grafts include the rising death toll of aneurysms throughout the world, coupled with the increasing proportion of the geriatric population. For instance, aortic aneurysm-related mortality is estimated to cause around 160,000–232,000 deaths annually across the globe with a survival rate of less than 20%. In addition to this, significant approval of thoracic vascular stent grafts by the FDA, along with surging awareness regarding these grafts, are further major factors that are estimated to expand the demand for thoracic vascular stent grafts over the forecast period.


Thoracic-Vascular-Stent-Grafts-Market
Get more information on this report: Request Free Sample PDF

Thoracic Vascular Stent Grafts Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Geriatric Population – As people get older, they face a slew of health issues. Moreover, people have a slow recovery rate in their old age, therefore elderly people face a variety of health problems that have a significant influence on their overall quality of life. As per the World Health Organization, in 2019, globally there, were approximately 1 billion people aged 60 and over. This number is expected to increase by nearly 1.4 billion by 2030 and 2.1 billion by 2050.
  • Growing Cases of Hypertension – Hypertension, often referred to as high or increased blood pressure, is a disorder characterized by chronically elevated blood vessel pressure. The harder the heart has to pump blood, the higher the pressure. Hypertension is a significant medical condition that raises the risk of heart, brain, and renal problems, among other problems. It is one of the leading causes of death worldwide. For instance, since 1990, the number of people with hypertension across the globe has doubled to 1.28 billion by 2021. Furthermore, more than 700 million people worldwide are currently coping with untreated hypertension.
  • Increasing Consumption of Tobacco – As per the World Health Organization statistics, every year, tobacco kills over 8 million people throughout the world. More than 7 million such deaths are caused by direct tobacco usage, whereas approximately 1.2 million are caused by nonsmokers being exposed to second-hand smoke.
  • Upsurge in Fast Food Consumption – For instance, approximately 51 million individuals in the United States prefer to eat fast food on any given day. Whereas, nearly 22% of individuals consume fast food a minimum of twice a week.
  • Rising Per Capita Income – According to the World Bank, compared to 2019, the global annual per capita income increased by 4.8% in 2021, while it only increased by 1.5% in 2019.

Challenges

  • High Cost of Thoracic Vascular Stent Grafts Treatment Thoracic vascular stent grafting is a relatively recent treatment modality in the vascular stent graft sector that has shown remarkable outcomes. Hence, this modality is expensive as compared with the other conventional methods and is anticipated to hamper the market growth over the projected time frame.
  • Growing Acceptance of Balloon Angioplasty
  • Hurdles Associated with Thoracic Stent Grafts

Thoracic Vascular Stent Grafts Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

6%

Base Year Market Size (2022)

USD 195 Million

Forecast Year Market Size (2035)

USD 284 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Thoracic Vascular Stent Grafts Segmentation

The global thoracic vascular stent grafts market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, medical centers, and others. Out of these types of segments, the hospitals segment is estimated to radically grow over the projected time frame. The growth of the segment can be attributed to the mounting incidences of CVDs throughout the world, coupled with a global increase in healthcare expenditure. For instance, as per the World Bank, global healthcare expenditure expanded to 9.83% in 2019 from 9.7% in 2018. Furthermore, the mounting number of patients visiting hospitals for diagnosis, followed by the availability of better medical reimbursement are some significant factors that are estimated to push the market growth further throughout the projected time frame.

The global thoracic vascular stent grafts market is also segmented and analyzed for demand and supply by product type into endovascular stent graft, hemodialysis access graft, peripheral vascular, and others. Amongst these segments, the endovascular stent graft segment is anticipated to grasp the largest market share, backed by the escalating adoption of the endovascular stent graft in the treatment of aneurysms including thoracic aortic aneurysms. Besides this, these stent grafts, in conjunction with antibiotics, can be utilized to treat mycotic aneurysms. In addition to this, escalating technology improvements in endovascular stent grafts have led to the development of a novel approach for treating a variety of aortic aneurysms, including those in the visceral arteries, this is another major factor that is estimated to significantly boost the growth of the market throughout the forecast period.

Our in-depth analysis of the global thoracic vascular stent grafts market includes the following segments:

                  By Type

  • Plastic
  • Metal Thoracic Vascular Stent Grafts

                 By Product Type

  • Endovascular Stent Graft
  • Hemodialysis Access Graft
  • Peripheral Vascular
  • Others

                By Application

  • Cardiac Aneurysm
  • Cardiovascular Diseases
  • Kidney Failure
  • Others

                By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Medical Centers
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Thoracic Vascular Stent Grafts Industry - Regional Synopsis

North America Market Forecast

The North America thoracic vascular stent grafts market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the significant rise in the aged population, coupled with the high prevalence of cardiovascular diseases (CVDs) in the region. According to the Centers for Disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Besides this, nearly 20.1 million adults aged 20 and above are influenced by coronary artery disease. Further, the dynamically surging technological developments, along with the availability of favorable reimbursement policies, are some further factors that are projected to accelerate the market’s growth during the forecast period in the region.

Asia Pacific Market Forecast

Further, the Asia Pacific thoracic vascular stent grafts market is also anticipated to display prominent market growth by the end of 2035. The growth of the market can be attributed to the dynamically increasing demand for minimally invasive surgical procedures, coupled with the surge in the ratio of patients with cardiovascular diseases in the region. For instance, in 2019, CVDs were the major cause of mortality in Asia, accounting for around 11 million deaths, or nearly 38% of overall deaths in the region. Along with this, the huge surge in chronic kidney disease, and growing healthcare infrastructure are some significant factors that are estimated to propel the market growth in the region in the projected time frame. In addition, a notable increase in favorable reimbursement policies is also anticipated to propel the market growth during the forecast period in the region.

Research Nester
Thoracic-Vascular-Stent-Grafts-Market-size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Thoracic Vascular Stent Grafts Landscape

top-features-companies
    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • JOTEC GmbH
    • Cook Group Incorporated
    • Terumo Corporation
    • Cardinal Health, Inc.
    • LeMaitre Vascular, Inc.
    • Merit Medical Systems, Inc.
    • Lombard Medical Ltd
    • Lifetech Scientific (Shenzhen) Co., Ltd.
    • Endologix LLC

In the News

  • Terumo Corporation has launched the Thoraflex Hybrid Device for the treatment of complex aortic arch disease. The single-use device is comprised of a Gelweave polyester graft coupled to a Nitinol self-expanding stent.

  • Lifetech Scientific (Shenzhen) Co., Ltd. has attained a formal written notice from the National Medical Products Administration (“NMPA”) authorizing the admission of the Artery Stent Graft System (chimney technology) into the NMPA Special Examination and Approval Procedure for Innovative Medical Services. This is the world's first stent graft system engineered specifically for "chimney technology", a mainstream technology for treating aortic dissection lesions.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4304
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing geriatric population, growing cases of hypertension, increasing consumption of tobacco, and upsurge in fast food consumption are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

High cost of thoracic vascular stent grafts treatment, growing acceptance of balloon angioplasty, and associated hurdles with thoracic stent grafts are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic, JOTEC GmbH, Cook Group Incorporated, Terumo Corporation, Cardinal Health, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, product type, application, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Thoracic Vascular Stent Grafts Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying